Funds · IMVT

Who owns IMVT?

Institutional ownership of Immunovant Inc. from Form 13F, Q2 2026

226 institutional managers reported holding Immunovant Inc. (IMVT) in Form 13F filings for Q2 2026, with 110,403,449 shares worth $4.3B. The largest reported holder was FMR LLC. Managers that filed both quarters cut a net 938,079 shares (-0.8%). 36 opened new positions and 24 sold out.

Funds holding
226
Value held
$4.3B
New / sold out
36 / 24
Net shares, same filers
-0.8%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of IMVT

FundValueShare of 13F holdingsSharesMove
FMR LLC$624M14.7%16,186,469Trimmed
Deep Track Capital, LP$360M8.5%9,341,151Trimmed
BlackRock, Inc.$277M6.5%7,180,897Added
Farallon Capital Management, L.l.c.$224M5.3%5,805,000Added
Baker Bros. Advisors LP$209M4.9%5,435,220Trimmed
State Street Corp$178M4.2%4,617,005Added
Morgan Stanley$175M4.1%4,534,833Added
TCG Crossover Management, LLC$172M4.0%4,457,988Unchanged
Vanguard Portfolio Management LLC$151M3.5%3,910,509Added
Vanguard Capital Management LLC$140M3.3%3,638,681Added
Jennison Associates LLC$128M3.0%3,310,238Added
RTW Investments, LP$122M2.9%3,177,849Unchanged
Two Seas Capital LP$121M2.9%3,148,505Trimmed
ADAR1 Capital Management, LLC$89.8M2.1%2,330,716Trimmed
Geode Capital Management, LLC$86.1M2.0%2,234,602Added
T. Rowe Price Investment Management, Inc.$85.6M2.0%2,222,101Trimmed
Woodline Partners LP$76.1M1.8%1,975,869Unchanged
Price T Rowe Associates Inc$70.5M1.7%1,829,210Added
Goldman Sachs Group Inc$67.5M1.6%1,751,183Trimmed
Armistice Capital, LLC$66.9M1.6%1,736,000Trimmed
Alpine Global Management, LLC$53.0M1.2%1,375,000Trimmed
Perceptive Advisors LLC$52.3M1.2%1,357,383Trimmed
D. E. Shaw & Co., Inc.$47.8M1.1%1,240,654New
Bank of America Corp$45.5M1.1%1,181,452Added
Susquehanna International Group, LLP$39.4M0.9%1,022,513Added

Share of 13F holdings is each fund's shares as a share of the 110,403,449 IMVT shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Farallon Capital Management, L.l.c. Added+$164M
  2. Price T Rowe Associates Inc Added+$57.4M
  3. D. E. Shaw & Co., Inc. New+$47.8M
  4. Morgan Stanley Added+$25.4M
  5. BlackRock, Inc. Added+$23.4M
  6. Renaissance Technologies LLC Added+$20.6M
  7. Susquehanna International Group, LLP Added+$15.6M
  8. Nuveen, LLC Added+$13.9M
  9. Millennium Management LLC New+$12.7M
  10. Bank of America Corp Added+$11.1M

Biggest sellers in Q2 2026

  1. Deep Track Capital, LP Trimmed-$84.2M
  2. Armistice Capital, LLC Trimmed-$70.5M
  3. T. Rowe Price Investment Management, Inc. Trimmed-$53.6M
  4. Alpine Global Management, LLC Trimmed-$48.6M
  5. Stempoint Capital LP Trimmed-$46.9M
  6. FMR LLC Trimmed-$29.3M
  7. Candriam S.C.A. Sold out-$16.9M
  8. Logos Global Management LP Trimmed-$15.8M
  9. Great Point Partners LLC Sold out-$13.6M
  10. ADAR1 Capital Management, LLC Trimmed-$13.4M

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $504M and sold $503M; 74 added and 79 trimmed.

Questions about IMVT ownership

Who owns IMVT stock?
226 institutional investment managers reported IMVT positions in their Form 13F filings for Q2 2026, holding 110,403,449 shares worth $4.3B in total. FMR LLC reported the largest position.
Are funds buying or selling IMVT?
In Q2 2026, 36 managers opened new IMVT positions, 74 added, 79 trimmed and 24 sold out. Managers that filed in both quarters sold a net 938,079 shares.
How current is this IMVT institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IMVT by CUSIP. Options are left out. IMVT news and filings · IMVT insider trades · Top funds